Demonstration of Biological and Immunological Equivalence of a Generic Glatiramer Acetate
{{output}}
Background: In April 2015, the US Food and Drug Administration approved the first generic glatiramer acetate, Glatopa® (M356), as fully substitutable for Copaxone® 20 mg/mL for relapsing forms of multiple sclerosis (MS). This a... ...
